Gene-drug interaction at the glucocorticoid receptor increases risk of squamous cell skin cancer

Journal of Investigative Dermatology

Volumn 127, Issue 8, 2007, Pages 1868-1870

  Patel, Anita S ^a   Karagas, Margaret R ^b   Perry, Ann E ^b   Spencer, Steven K ^b   Nelson, Heather H ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ARTICLE; BASAL CELL CARCINOMA; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SAFETY; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UNITED STATES;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GLUCOCORTICOIDS; HUMANS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; SKIN NEOPLASMS;

EID: 34447546650     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700798     Document Type: Article

References (10)

1. De Kloat ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301
2. Euvrad S, Kanitakis J, Claudy A (2003) Skin cancer after organ transplantation. Neuro Engl J Med 348:1681-91
3. Karagas M, Greenberg ER, Spencer SK, Stukel TA, Mott LA (1999) Increase in incidence rates of basal cell carcinoma and squamous cell skin cancer in New Hampshire USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81:555-9
4. Karagas MR, Cushing GL, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW (2001) Non-melanoma skin cancers and glucocorticoid therapy. British J Cancer 85:683-6
5. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774-8
6. Schwabe U (1996) Corticosteroide. In: Arizneiverordnungs-Report 1996. P. Schwabe (ed.) Stuttgart: Fischer, pp 184-8
7. Sorenson HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR (2004) Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Institute 96:709-11
8. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE, Donn R (2004) Glucocorticoid sensitivity is determined by a specific glucocoticoid receptor haplotype. J Clin Endocrinol Metab 89:892-7
9. Weinstock MA, Bogaars HA, Ashley M, Litle V, Bilodeau E, Kimmel S (1991) Nonmelanoma skin cancer mortality: a population-based study. Arch Dermatol 127:1194-7
10. Wust S, van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH (2004) Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocorticol responses to psychosocial stress. J Clin Endocrinol Metab 89:565-73